Effect of Vitamin D on Retinoblastoma Protein in Prediabetic Individuals

Article ID: e310323215281 Pages: 9

  • * (Excluding Mailing and Handling)

Abstract

About 50.8 million people were diagnosed with diabetes in 2011; the count has increased by 10 million in the last five years. Type-1 diabetes could occur at any age, but predominantly in children and young adults. The risk of developing type II diabetes mellitus in the offspring of parents with DM II is 40% if one parent has DM II and approaches 70% if both parents have DM II. The process of developing diabetes from normal glucose tolerance is continuous, with insulin resistance being the first stage. As prediabetes progresses slowly to DM II, it may take approximately 15-20 years for an individual to become diabetic. This progression can be prevented or delayed by taking some precautions and making some lifestyle amendments, e.g., reducing weight by 5-7% of total body weight if obese, etc. Retinoblastoma protein is one of the pocket proteins that act as crucial gatekeepers during the G1/S transition in the cell cycle. A loss or defect in single- cell cycle activators (especially CDK4 and CDK6) leads to cell failure. In diabetic or stress conditions, p53 becomes a transcription factor, resulting in the transactivation of CKIs, which leads to cell cycle arrest, cell senescence, or cell apoptosis. Vitamin D affects insulin sensitivity by increasing insulin receptors or the sensitivity of insulin receptors to insulin. It also affects peroxisome proliferator-activated receptors (PPAR) and extracellular calcium. These influence both insulin resistance and secretion mechanisms, undertaking the pathogenesis of type II diabetes. The study confines a marked decrement in the levels of random and fasting blood glucose levels upon regular vitamin D intake, along with a significant elevation of retinoblastoma protein levels in the circulatory system. The most critical risk factor for the occurrence of the condition came out to be family history, showing that patients with first-degree relatives with diabetes are more susceptible. Factors such as physical inactivity or comorbid conditions further aggravate the risk of developing the disease. The increase in pRB levels caused by vitamin D therapy in prediabetic patients directly influences blood glucose levels. pRB is supposed to play a role in maintaining blood sugar levels. The results of this study could be used for further studies to evaluate the role of vitamin D and pRB in regeneration therapy for beta cells in prediabetics.

[1]
Nakrani MN, Wineland RH, Anjum F. Physiology, glucose metabolism 2022 Jul 25.StatPearls. Treasure Island, FL: StatPearls Publishing 2022.
[2]
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2009; 32(S1): S62-7.
[PMID: 19118289]
[3]
Sandu M-M, Protasiewicz DC. Firănescu AG, Lăcătuşu EC, Bîcu ML, ţa M. Data regarding the prevalence and incidence of diabetes mellitus and prediabetes. Rom J Diabetes Nutr Metab Dis 2016; 23(1): 95-103.
[http://dx.doi.org/10.1515/rjdnmd-2016-0012]
[4]
Sujatha . Prevalence of Diabetes in India. 2015.
[5]
Anjana RM, Deepa M, Pradeepa R, et al. Prevalence of diabetes and prediabetes in 15 states of India: Results from the ICMR–INDIAB population-based cross-sectional study. Lancet Diabetes Endocrinol 2017; 5(8): 585-96.
[http://dx.doi.org/10.1016/S2213-8587(17)30174-2] [PMID: 28601585]
[6]
Kaveeshwar S, Cornwall J. The current state of diabetes mellitus in India. Australas Med J 2014; 7(1): 45-8.
[http://dx.doi.org/10.4066/AMJ.2014.1979] [PMID: 24567766]
[7]
Mohan V, Pradeepa GR. Epidemiology of diabetes in different regions of India. Health Administrator 2009; 22(1): 1-18.
[8]
Katsarou A, Gudbjörnsdottir S, Rawshani A, et al. Type 1 diabetes mellitus. Nat Rev Dis Primers 2017; 3(1): 17016.
[http://dx.doi.org/10.1038/nrdp.2017.16] [PMID: 28358037]
[9]
Domínguez Avila J, Rodrigo García J, González Aguilar G, de la Rosa L. The antidiabetic mechanisms of polyphenols related to increased glucagon-like peptide-1 (GLP1) and insulin signaling. Molecules 2017; 22(6): 903.
[http://dx.doi.org/10.3390/molecules22060903] [PMID: 28556815]
[10]
Mitri J, Muraru MD, Pittas AG. Vitamin D and type 2 diabetes: A systematic review. Eur J Clin Nutr 2011; 65(9): 1005-15.
[http://dx.doi.org/10.1038/ejcn.2011.118] [PMID: 21731035]
[11]
Prabhu S. Genetic and biochemical risk factors for type 2 diabetes mellitus. Indian J Biotechnol 2013; 12(4): 447-50.
[12]
One part of managing type 2 diabetes is managing A1C.. Available from: https://www.niddk.nih.gov/health-information/diabetes/over view/risk-factors-type-2-diabetes
[13]
Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: An update. Hypertension 2001; 37(4): 1053-9.
[http://dx.doi.org/10.1161/01.HYP.37.4.1053] [PMID: 11304502]
[14]
Mohan H. Textbook of pathology. JaypeeDigital 2010.
[http://dx.doi.org/10.5005/jp/books/11091]
[15]
Sladek R, Rocheleau G, Rung J, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007; 445(7130): 881-5.
[http://dx.doi.org/10.1038/nature05616] [PMID: 17293876]
[16]
Schwartz SS, Epstein S, Corkey BE, Grant SFA, Gavin JR III, Aguilar RB. The time is right for a new classification system for diabetes: Rationale and implications of the β-cell–centric classification schema. Diabetes Care 2016; 39(2): 179-86.
[http://dx.doi.org/10.2337/dc15-1585] [PMID: 26798148]
[17]
Ali O. Genetics of type 2 diabetes. World J Diabetes 2013; 4(4): 114-23.
[http://dx.doi.org/10.4239/wjd.v4.i4.114] [PMID: 23961321]
[18]
Scott RA, Langenberg C, Sharp SJ, et al. The link between family history and risk of type 2 diabetes is not explained by anthropometric, lifestyle or genetic risk factors: The EPIC-InterAct study. Diabetologia 2013; 56(1): 60-9.
[http://dx.doi.org/10.1007/s00125-012-2715-x] [PMID: 23052052]
[19]
Muktabhant B, Sanchaisuriya P, Trakulwong M, Mingchai R, Schelp FP. A first-degree relative with diabetes mellitus is an important risk factor for rural Thai villagers to develop type 2 diabetes mellitus. Asia Pac J Public Health 2015; 27(4): 385-93.
[http://dx.doi.org/10.1177/1010539514555861] [PMID: 25380670]
[20]
Gupta M, Saini R, Jaswal S, Lehl S, Jesrani G, Gupta S. Prevalence of risk factors for diabetes in adult offspring of type 2 diabetes mellitus patients. Int J Noncommun Dis 2022; 7(4): 177.
[http://dx.doi.org/10.4103/jncd.jncd_82_22]
[21]
Bhalerao SD, Somannavar M. Risk factors for type-2 diabetes mellitus in rural population of north karnatka: A community-based cross sectional study. Int J Pharma Bio Sci 2014; 3(1): 1-14.
[22]
Boden G, Shulman GI. Free fatty acids in obesity and type 2 diabetes: Defining their role in the development of insulin resistance and β-cell dysfunction. Eur J Clin Invest 2002; 32(S3): 14-23.
[http://dx.doi.org/10.1046/j.1365-2362.32.s3.3.x] [PMID: 12028371]
[23]
Roden M, Price TB, Perseghin G, et al. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 1996; 97(12): 2859-65.
[http://dx.doi.org/10.1172/JCI118742] [PMID: 8675698]
[24]
Cantley J, Ashcroft FM Q. &A: Insulin secretion and type 2 diabetes: Why do β-cells fail? BMC Biol 2015; 13(1): 33.
[http://dx.doi.org/10.1186/s12915-015-0140-6] [PMID: 25982967]
[25]
Bergman M. Pathophysiology of prediabetes and treatment implications for the prevention of type 2 diabetes mellitus. Endocrine 2013; 43(3): 504-13.
[http://dx.doi.org/10.1007/s12020-012-9830-9] [PMID: 23132321]
[26]
American Diabetes Association. Approaches to glycemic treatment. Diabetes Care 2016; 39(S1): S52-9.
[http://dx.doi.org/10.2337/dc16-S010] [PMID: 26696682]
[27]
Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of diabetes and diabetes-related complications. Phys Ther 2008; 88(11): 1254-64.
[http://dx.doi.org/10.2522/ptj.20080020] [PMID: 18801858]
[28]
IDF Diabetes Atlas. 7th ed International Diabetes Federation. 2016.
[29]
Junedi S, Nuhaedar J. Characteristics of outpatient pre diabetes dr. dody sarjoto. Indian J Public Health Res Dev 2020; 3(1): 2058-61.
[http://dx.doi.org/10.37506/ijphrd.v11i3.2396]
[31]
Hamiel PO, Zeitler P. Prediabetes: A high-risk state for developing diabetes. Lancet 2013; 379(9833): 2279-90.
[http://dx.doi.org/10.1016/S0140-6736(12)60283-9]
[32]
Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: A high-risk state for diabetes development. Lancet 2012; 379(9833): 2279-90.
[http://dx.doi.org/10.1016/S0140-6736(12)60283-9] [PMID: 22683128]
[33]
Weiss R. Impaired glucose tolerance and risk factors for progression to type 2 diabetes in youth. Pediatr Diabetes 2007; 8(S9): 70-5.
[http://dx.doi.org/10.1111/j.1399-5448.2007.00336.x] [PMID: 17991135]
[34]
Siu AL. Screening for abnormal blood glucose and type 2 diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2015; 163(11): 861-8.
[http://dx.doi.org/10.7326/M15-2345] [PMID: 26501513]
[35]
Handelsman Y, Bloomgarden ZT, Grunberger G, et al. American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan-2015. Endocr Pract 2015; 21(S1): 1-87.
[http://dx.doi.org/10.4158/EP15672.GLSUPPL] [PMID: 25869408]
[36]
American Diabetes Association. (2) Classification and diagnosis of diabetes. Diabetes Care 2015; 38(S1): S8-S16.
[http://dx.doi.org/10.2337/dc15-S005] [PMID: 25537714]
[37]
Pottie K, Jaramillo A, Lewin G, et al. Recommendations on screening for type 2 diabetes in adults. CMAJ 2012; 184(15): 1687-96.
[http://dx.doi.org/10.1503/cmaj.120732] [PMID: 23073674]
[38]
Makrilakis K, Liatis S, Grammatikou S, et al. Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece. Diabetes Metab 2011; 37(2): 144-51.
[http://dx.doi.org/10.1016/j.diabet.2010.09.006] [PMID: 21144787]
[39]
Robinson CA, Agarwal G, Nerenberg K. Validating the CANRISK prognostic model for assessing diabetes risk in Canada’s multi-ethnic population. Chronic Dis Inj Can 2011; 32(1): 19-31.
[http://dx.doi.org/10.24095/hpcdp.32.1.04] [PMID: 22153173]
[40]
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014; 37(S1): S81-90.
[http://dx.doi.org/10.2337/dc14-S081] [PMID: 24357215]
[41]
Fiaschi-TN. Bigatel TA. Survey of human pancreatic β-cell G1/ S proteome reveals a potential therapeutic role for cdk-6 and cyclin D1 in enhancing human β-cell replication and function In vivo. Diabetes 2009; 58(4): 882-93.
[http://dx.doi.org/10.2337/db08-0631] [PMID: 19136653]
[42]
Vasavada RC, Cozar-Castellano I, Sipula D, Stewart AF. Tissue-specific deletion of the retinoblastoma protein in the pancreatic beta-cell has limited effects on beta-cell replication, mass, and function. Diabetes 2007; 56(1): 57-64.
[http://dx.doi.org/10.2337/db06-0517] [PMID: 17192465]
[43]
Cobrinik D. Pocket proteins and cell cycle control. Oncogene 2005; 24(17): 2796-809.
[http://dx.doi.org/10.1038/sj.onc.1208619] [PMID: 15838516]
[44]
Nevins JR. E2F: A link between the Rb tumor suppressor protein and viral oncoproteins. Science 1992; 258(5081): 424-9.
[http://dx.doi.org/10.1126/science.1411535] [PMID: 1411535]
[45]
Flemington EK, Speck SH, Kaelin WG Jr. E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc Natl Acad Sci USA 1993; 90(15): 6914-8.
[http://dx.doi.org/10.1073/pnas.90.15.6914] [PMID: 8346196]
[46]
Lees JA, Saito M, Vidal M, et al. The retinoblastoma protein binds to a family of E2F transcription factors. Mol Cell Biol 1993; 13(12): 7813-25.
[PMID: 8246996]
[47]
Lee C, Chang JH, Lee HS, Cho Y. Structural basis for the recognition of the E2F transactivation domain by the retinoblastoma tumor suppressor. Genes Dev 2002; 16(24): 3199-212.
[http://dx.doi.org/10.1101/gad.1046102] [PMID: 12502741]
[48]
DeCaprio JA, Ludlow JW, Lynch D, et al. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 1989; 58(6): 1085-95.
[http://dx.doi.org/10.1016/0092-8674(89)90507-2] [PMID: 2673542]
[49]
Ludlow JW, Shon J, Pipas JM, et al. The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T. Cell 1990; 60(3): 387-96.
[http://dx.doi.org/10.1016/0092-8674(90)90590-b] [PMID: 2154332]
[50]
Helin K, Lees JA, Vidal M, Dyson N, Harlow E, Fattaey A. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 1992; 70(2): 337-50.
[http://dx.doi.org/10.1016/0092-8674(92)90107-N] [PMID: 1638634]
[51]
Blagosklonny MV, Pardee AB. The restriction point of the cell cycle. Cell Cycle 2002; 1(2): 102-9.
[http://dx.doi.org/10.4161/cc.1.2.108] [PMID: 12429916]
[52]
Pestell RG, Albanese C, Reutens AT, Segall JE, Lee RJ, Arnold A. The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr Rev 1999; 20(4): 501-34.
[PMID: 10453356]
[53]
Cozar-Castellano I, Fiaschi-Taesch N, Bigatel TA, et al. Molecular control of cell cycle progression in the pancreatic β-cell. Endocr Rev 2006; 27(4): 356-70.
[http://dx.doi.org/10.1210/er.2006-0004] [PMID: 16638909]
[54]
Kung CP, Murphy ME. The role of the p53 tumor suppressor in metabolism and diabetes. J Endocrinol 2016; 231(2): R61-75.
[http://dx.doi.org/10.1530/JOE-16-0324] [PMID: 27613337]
[55]
Hummel D, Aggarwal A, Borka K, Bajna E, Kállay E, Horváth HC. The vitamin D system is deregulated in pancreatic diseases. J Steroid Biochem Mol Biol 2014; 144(Pt B): 402-9.
[http://dx.doi.org/10.1016/j.jsbmb.2014.07.011] [PMID: 25090635]
[56]
Norman AW. From vitamin D to hormone D: Fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 2008; 88(2): S491-9.
[http://dx.doi.org/10.1093/ajcn/88.2.491S] [PMID: 18689389]
[57]
Hoseini SA, Aminorroaya A, Iraj B, Amini M. The effects of oral vitamin D on insulin resistance in pre-diabetic patients. J Res Med Sci 2013; 18(1): 47-51.
[PMID: 23900423]
[58]
Bhoora S, Punchoo R. Policing cancer: Vitamin D arrests the cell cycle. Int J Mol Sci 2020; 21(23): 9296.
[http://dx.doi.org/10.3390/ijms21239296]